Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting

Journal of Thoracic Oncology

Volumn 10, Issue 2, 2015, Pages 309-315

  Bylicki, Olivier ^a   Rouvière, Damien ^b   Cassier, Philippe ^c   Chalabreysse, Lara ^d   Levard, Alice ^c   Maury, Jean Michel ^a   Margery, Jacques ^e   Blay, Jean Yves ^c   Mazières, Julien ^b   Girard, Nicolas ^a  

^a LOUIS PRADEL HOSPITAL   (France)

^b SERVICE DE PNEUMOLOGIE   (France)

^c CENTRE LÉON BÉRARD   (France)

^d HOSPICES CIVILS DE LYON   (France)

^e PERCY MILITARY HOSPITAL   (France)

Author keywords

Chemotherapy; Pleura; Solitary fibrous tumor; Surgery; Trabectedin

Indexed keywords

CISPLATIN; DACARBAZINE; DOCETAXEL; DOXORUBICIN; GEMCITABINE; IFOSFAMIDE; MESNA; NAVELBINE; PACLITAXEL; PAZOPANIB; PEMETREXED; SUNITINIB; TRABECTEDIN;

ADULT; AGED; ANTIANGIOGENIC THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; FEMALE; FOLLOW UP; HEALTH CARE PRACTICE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MONOTHERAPY; MULTICENTER STUDY; OVERALL SURVIVAL; PLEURA TUMOR; POSTOPERATIVE CARE; PREDICTIVE VALUE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RECURRENCE RISK; RETROSPECTIVE STUDY; SOLITARY FIBROUS TUMOR; TUMOR RECURRENCE; VERY ELDERLY; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE COURSE; PATHOLOGY; PLEURAL NEOPLASMS; PROGNOSIS; SOLITARY FIBROUS TUMOR, PLEURAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; PLEURAL NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SOLITARY FIBROUS TUMOR, PLEURAL; TREATMENT OUTCOME;

EID: 84922323014     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000401     Document Type: Article

References (31)

1. Dervan PA, Tobin B, O'Connor M. Solitary (localized) fibrous mesothelioma: Evidence against mesothelial cell origin. Histopathology 1986;10:867-875
2. Chan JK. Solitary fibrous tumour-everywhere, and a diagnosis in vogue. Histopathology 1997;31:568-576
3. De Perrot M, Fischer S, Bründler MA, Sekine Y, Keshavjee S. Solitary fibrous tumors of the pleura. Ann Thorac Surg 2002;74:285-293
4. Lahon B, Mercier O, Fadel E, et al. Solitary fibrous tumor of the pleura: Outcomes of 157 complete resections in a single center. Ann Thorac Surg 2012;94:394-400
5. Magdeleinat P, Alifano M, Petino A, et al. Solitary fibrous tumors of the pleura: Clinical characteristics, surgical treatment and outcome. Eur J Cardio-Thorac Surg 2002;21:1087-1093
6. Rena O, Filosso PL, Papalia E, et al. Solitary fibrous tumour of the pleura: Surgical treatment. Eur J Cardio-Thorac Surg 2001;19:185-189
7. Sung SH, Chang JW, Kim J, Lee KS, Han J, Park SI. Solitary fibrous tumors of the pleura: Surgical outcome and clinical course. Ann Thorac Surg 2005;79:303-307
8. Cardillo G, Carbone L, Carleo F, et al. Solitary fibrous tumors of the pleura: An analysis of 110 patients treated in a single institution. Ann Thorac Surg 2009;88:1632-1637
9. Lococo F, Cesario A, Cardillo G, et al. Malignant solitary fibrous tumors of the pleura: Retrospective review of a multicenter series. J Thorac Oncol 2012;7:1698-1706
10. England DM, Hochholzer L, McCarthy MJ. Localized benign and malignant fibrous tumors of the pleura. A clinicopathologic review of 223 cases. Am J Surg Pathol 1989;13:640-658
11. de Perrot M, Kurt AM, Robert JH, Borisch B, Spiliopoulos A. Clinical behavior of solitary fibrous tumors of the pleura. Ann Thorac Surg 1999;67:1456-1459
12. Park MS, Ravi V, Conley A, et al. The role of chemotherapy in advanced solitary fibrous tumors: A retrospective analysis. Clin Sarcoma Res 2013;3:7
13. Stacchiotti S, Libertini M, Negri T, et al. Response to chemotherapy of solitary fibrous tumour: A retrospective study. Eur J Cancer 2013;49:2376-2383
14. Constantinidou A, Jones RL, Olmos D, et al. Conventional anthracyclinebased chemotherapy has limited efficacy in solitary fibrous tumour. Acta Oncol Stockh Swed 2012;51:550-554
15. Domont J, Massard C, Lassau N, Armand JP, Le Cesne A, Soria JC. Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed malignant haemangioperyctoma/solitary fibrous tumour. Invest New Drugs 2010;28:199-202
16. Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009;45:228-247
17. Lorillou M, Thivolet-Béjui F, Tronc F, Girard N, Cordier JF, Cottin V. Clubbing, arthralgia and a large intrathoracic mass. Respiration 2012;84:150-154
18. Rosado-de-Christenson ML, Abbott GF, McAdams HP, Franks TJ, Galvin JR. From the archives of the AFIP: Localized fibrous tumor of the pleura. Radiographics 2003.23:759-783
19. Antman K, Crowley J, Balcerzak SP, et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:1276-1285
20. Levard A, Derbel O, Méeus P, et al. Outcome of patients with advanced solitary fibrous tumors: The Centre Léon Bérard experience. BMC Cancer 2013;13:109
21. Blay JY, Italiano A, Ray-Coquard I, et al. Long-term outcome and effect of maintenance therapy in patients with advanced sarcoma treated with trabectedin: An analysis of 181 patients of the French ATU compassionate use program. BMC Cancer 2013;13:64
22. Chaigneau L, Kalbacher E, Thiery-Vuillemin A, et al. Efficacy of trabectedin in metastatic solitary fibrous tumor. Rare Tumors 2011;3:e29
23. Park MS, Patel SR, Ludwig JA, et al. Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor. Cancer 2011;117:4939-4947
24. De Pas T, Toffalorio F, Colombo P, et al. Brief report: Activity of imatinib in a patient with platelet-derived-growth-factor receptor positive malignant solitary fibrous tumor of the pleura. J Thorac Oncol 2008;3:938-941
25. Stacchiotti S, Negri T, Palassini E, et al. Sunitinib malate and figitumumab in solitary fibrous tumor: Patterns and molecular bases of tumor response. Mol Cancer Ther 2010;9:1286-1297
26. Sleijfer S, Ray-Coquard I, Papai Z, et al. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: A phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). J Clin Oncol 2009;27:3126-3132
27. Prunotto M, Bosco M, Daniele L, et al. Imatinib inhibits in vitro proliferation of cells derived from a pleural solitary fibrous tumor expressing platelet-derived growth factor receptor-beta. Lung Cancer 2009;64:244-246
28. Rossi G, Schirosi L, Giovanardi F, Sartori G, Paci M, Cavazza A. Pleural malignant solitary fibrous tumor with sarcomatous overgrowth showing PDGFRbeta mutation. Chest 2006;130:581-583
29. Pavelić K, Pavelić ZP, Cabrijan T, Karner I, Samarzija M, Stambrook PJ. Insulin-like growth factor family in malignant haemangiopericytomas: The expression and role of insulin-like growth factor I receptor. J Pathol 1999;188:69-75
30. Chmielecki J, Crago AM, Rosenberg M, et al. Whole-exome sequencing identifies a recurrent NAB2-STAT6 fusion in solitary fibrous tumors. Nat Genet 2013;45:131-132
31. Barthelmes S, Geddert H, Boltze C, et al. Solitary fibrous tumors/hemangiopericytomas with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicopathological features. Am J Pathol 2014;184:1209-1218